Strategic Partnerships CORE Diagnostics has a track record of forming strategic collaborations with oncology-focused platforms and cancer care providers, such as partnerships with Oncoshot, CanCertain Healthcare, and HealthCare Inc. This indicates a sales opportunity to offer integrated testing solutions or federated data exchange capabilities to oncology trials, precision oncology programs, and cancer treatment centers.
Precision Oncology The company emphasizes next generation diagnostics for disease stratification and therapy selection, with recent collaborations around multi-cancer early detection and precision cancer testing. This presents a sales angle to upsell advanced molecular panels, MCED tests, and theranostic solutions to hospitals and specialty cancer centers.
Tech Enablement CORE Diagnostics runs on cloud and e-commerce oriented tech stack (AWS, WordPress, Shopify, WooCommerce, WhatsApp Business). There is an opportunity to propose scalable LIMS integrations, secure data exchange, patient engagement tools, and digital ordering for high-throughput diagnostic workflows to mid-to-large hospitals and diagnostic networks.
Growth Readiness With a revenue range of 10–25 million and a growing partner ecosystem, CORE appears positioned for scale. Sales conversations can target expanding hospital networks, private labs, and clinical trial units seeking high-end diagnostics, faster turnaround, and reliable second opinions to differentiate their offerings.
Market Positioning As a mid-sized Indian diagnostics provider focused on advanced testing and rapid, actionable results, CORE can be approached for enterprise-level contracts, national hospital partnerships, and expansion into international markets where precision diagnostics and federated data exchange add strategic value to trial sponsors and oncology programs.